JP2017503024A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503024A5
JP2017503024A5 JP2016562455A JP2016562455A JP2017503024A5 JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5 JP 2016562455 A JP2016562455 A JP 2016562455A JP 2016562455 A JP2016562455 A JP 2016562455A JP 2017503024 A5 JP2017503024 A5 JP 2017503024A5
Authority
JP
Japan
Prior art keywords
group
formula
member selected
cyano
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016562455A
Other languages
English (en)
Japanese (ja)
Other versions
JP6626454B2 (ja
JP2017503024A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/072291 external-priority patent/WO2015103060A1/en
Publication of JP2017503024A publication Critical patent/JP2017503024A/ja
Publication of JP2017503024A5 publication Critical patent/JP2017503024A5/ja
Application granted granted Critical
Publication of JP6626454B2 publication Critical patent/JP6626454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016562455A 2014-01-06 2014-12-23 Trpa1モジュレーター Active JP6626454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461924119P 2014-01-06 2014-01-06
US61/924,119 2014-01-06
PCT/US2014/072291 WO2015103060A1 (en) 2014-01-06 2014-12-23 Trpa1 modulators

Publications (3)

Publication Number Publication Date
JP2017503024A JP2017503024A (ja) 2017-01-26
JP2017503024A5 true JP2017503024A5 (OSRAM) 2018-02-08
JP6626454B2 JP6626454B2 (ja) 2019-12-25

Family

ID=53493929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016562455A Active JP6626454B2 (ja) 2014-01-06 2014-12-23 Trpa1モジュレーター

Country Status (10)

Country Link
US (2) US9951046B2 (OSRAM)
EP (1) EP3092228A4 (OSRAM)
JP (1) JP6626454B2 (OSRAM)
CN (1) CN106061969B (OSRAM)
AU (1) AU2014374043B2 (OSRAM)
CA (1) CA2936111C (OSRAM)
IL (1) IL246625B (OSRAM)
SG (1) SG11201605559VA (OSRAM)
WO (1) WO2015103060A1 (OSRAM)
ZA (1) ZA201605332B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2936111C (en) 2014-01-06 2023-03-14 Algomedix, Inc. Trpa1 modulators
CA3006434C (en) * 2015-11-27 2021-03-16 Taiho Pharmaceutical Co., Ltd. Biphenyl compound or salt thereof
EP3481808A4 (en) * 2016-07-06 2020-07-15 Algomedix, Inc. TRPA1 ANTAGONISTS FOR THE TREATMENT OF DRY EYE SYNDROME, EYE PAIN AND INFLAMMATION
CN106580984A (zh) * 2016-12-12 2017-04-26 高群 一种治疗高血脂症的药物组合物
JP7178357B2 (ja) * 2017-03-07 2022-11-25 エフ.ホフマン-ラ ロシュ アーゲー オキサジアゾール一過性受容器電位チャネル阻害剤
HUE062769T2 (hu) 2017-05-26 2023-12-28 Taiho Pharmaceutical Co Ltd Antitumor potenciátor bifenil vegyület felhasználásával
CN110740991B (zh) 2017-05-26 2023-07-04 大鹏药品工业株式会社 新型联苯化合物或其盐
EP3633380A4 (en) 2017-05-31 2021-02-24 Taiho Pharmaceutical Co., Ltd. METHOD OF PREDICTING THE THERAPEUTIC EFFECT OF LSD1 INHIBITORS ON THE BASIS OF THE EXPRESSION OF INSM1
CN109596818B (zh) * 2018-12-13 2024-03-19 丁蓉 一种基于电生理学分析当归四逆汤预防奥沙利铂神经毒性机制的研究方法
WO2021095840A1 (en) 2019-11-13 2021-05-20 Taiho Pharmaceutical Co., Ltd. METHODS OF TREATING LSD1-RELATED DISEASES and Disorders WITH LSD1 INHIBITORS
JP7688339B2 (ja) * 2020-01-22 2025-06-04 国立研究開発法人理化学研究所 新規化合物、およびその利用
FR3114235A1 (fr) 2020-09-18 2022-03-25 Université Grenoble Alpes Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer
CN112694436B (zh) * 2020-12-30 2022-07-08 济南周行医药科技有限公司 一种槟榔碱的合成方法
IT202100015098A1 (it) 2021-06-09 2022-12-09 Flonext S R L Composto antagonista del canale trpa1 per uso in patologie degenerative della retina
WO2024099404A1 (zh) * 2022-11-10 2024-05-16 北京普祺医药科技股份有限公司 一种含氮螺环类化合物、药物组合物以及其用途
CN121735827A (zh) * 2026-02-27 2026-03-27 泰励生物科技(上海)有限公司 哌啶酮类化合物的制备方法
CN121735881A (zh) * 2026-02-27 2026-03-27 泰励生物科技(上海)有限公司 砜类化合物的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8429128D0 (en) * 1984-11-17 1984-12-27 Fisons Plc Heterocyclic compounds
EP0178035B1 (en) * 1984-05-12 1990-01-03 FISONS plc Anti-inflammatory 1,n-diarylpyrazol-3-amines, compositions containing them and processes for their preparation
JP2002502380A (ja) * 1997-05-22 2002-01-22 ジー.ディー.サール アンド カンパニー p38キナーゼ阻害剤としてのピラゾール誘導体
JP2002514640A (ja) * 1998-05-14 2002-05-21 ジー・ディー・サール・アンド・カンパニー p38キナーゼ阻害剤としての1,5−ジアリール置換ピラゾール類
AU2004200420A1 (en) * 2003-03-11 2004-09-30 Astellas Pharma Inc. Inhibitor of cyclooxygenase
CN1809351A (zh) * 2003-04-24 2006-07-26 麦克公司 Akt活性抑制剂
ES2297502T3 (es) 2003-10-23 2008-05-01 F. Hoffmann-La Roche Ag Derivados de triaza-espiropiperidinas para uso como inhibidores de glyt-1 en el tratamiento de trastornos neurologicos y neuropsiquiatricos.
ZA200605252B (en) * 2003-12-26 2007-11-28 Daiichi Seiyaku Co Amidopyrazole derivative
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
GB0417910D0 (en) * 2004-08-11 2004-09-15 Novartis Ag Organic compounds
WO2007002563A1 (en) 2005-06-27 2007-01-04 Exelixis, Inc. Imidazole based lxr modulators
AU2006327181A1 (en) 2005-12-22 2007-06-28 Hydra Biosciences, Inc. TRPA1 inhibitors for treating pain
US7977358B2 (en) 2007-07-26 2011-07-12 Hoffmann-La Roche Inc. Pyrazol derivatives
CN101959861A (zh) 2008-01-04 2011-01-26 雅培制药有限公司 Trpa1拮抗剂
EP2300440B1 (en) 2008-06-02 2013-02-27 Janssen Pharmaceutica, N.V. 3,4-dihydropyrimidine trpa1 antagonists
WO2010125469A1 (en) * 2009-04-29 2010-11-04 Glenmark Pharmaceuticals, S.A. Pyrimidinedione-fused heterocyclic compounds as trpa1 modulators
EP2485737B1 (en) 2009-10-07 2014-06-25 Merck Sharp & Dohme Corp. Novel trpa1 antagonists
WO2012174362A1 (en) 2011-06-17 2012-12-20 Research Triangle Institute Pyrazole derivatives as cannabinoid receptor 1 antagonists
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
SI2903965T1 (sl) 2012-10-01 2017-07-31 Orion Corporation Derivati n-prop-2-inil karboksamida in njihova uporaba kot antagonisti trpa1
CA2936111C (en) 2014-01-06 2023-03-14 Algomedix, Inc. Trpa1 modulators
EP3481808A4 (en) 2016-07-06 2020-07-15 Algomedix, Inc. TRPA1 ANTAGONISTS FOR THE TREATMENT OF DRY EYE SYNDROME, EYE PAIN AND INFLAMMATION

Similar Documents

Publication Publication Date Title
US11957657B2 (en) Combination therapies using immuno-dash inhibitors and PGE2 antagonists
HRP20140919T1 (hr) Spojevi koji moduliraju androgene receptore
RU2012121577A (ru) Замещенные 3-фенилпропионовые кислоты и их применение
JP2012521428A5 (OSRAM)
HRP20110456T1 (hr) Derivati indola kao agonisti receptora s1p1
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
RU2014103587A (ru) Производные циклических аминов в качестве антагонистов рецептора ер4
JP2017518981A5 (OSRAM)
RU2012125372A (ru) Производные пиразола в качестве ингибиторов 11-бета-hsd1
RU2010136974A (ru) Способы лечения воспалительной боли
JP2013523746A5 (OSRAM)
EA201300342A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
JP2017505293A5 (OSRAM)
RU2010102990A (ru) Производные оксадиазолов в качестве ингибиторов dgat
US20230372372A1 (en) Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists
JP2025516005A5 (OSRAM)
JP2022521955A5 (OSRAM)
JP2020505354A5 (OSRAM)
JP2015524470A5 (OSRAM)
RU2014102948A (ru) Вакцинная композиция для мукозального введения
JP2018536678A5 (OSRAM)
US20060217431A1 (en) Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a COX-2 inhibitor
PE20121403A1 (es) Nuevas sales de fumarato de un antagonista del receptor de histamina h3
JP2009504612A5 (OSRAM)
JP2012505225A5 (OSRAM)